## Variants and diseases

### [Relational list using ClinVar](https://www.ncbi.nlm.nih.gov/clinvar/)

|Disease|Gene|Variants|
|-------|----|--------|
|Hemochromatosis|HJV|NM_213653.3:c.959G>T|
|Thalassemia|HBB|NM_000518.5(HBB):c.92_94dup (p.Arg31dup)|
|Haemophilia|VWF|NM_000552.4(VWF):c.4751A>G (p.Tyr1584Cys)|
|Cystic Fibrosis|EP300|	NM_001429.4(EP300):c.4026-9A>G	|
|Tay sachs disease|	HEXA	|	NM_000520.6(HEXA):c.1385A>T (p.Glu462Val)	|
|Fragile X syndrome|FMR1|NC_000023.10:g.146993570GGC[(45_54)]	|
|Huntington's disease|HTT, LOC109461479|NM_002111.8(HTT):c.52CAG[(36_39)]	|


### [Relational list using ClinGen](https://clinicalgenome.org/)
|Gene|Gene name|Chromosomal location|Gene product|Disease|
|----|---------|--------------------|------------|-------|
|CFTR|CF transmembrane conductance regulator|7q31.2|epithelial ion channel, transport of chloride ions across the cell membrane|Cystic fibrosis|
|CYBB|cytochrome b-245 beta chain	|Xp21.1-p11.4| 	Component of membrane-bound oxidase of phagocytes generating superoxides	|	granulomatous diseaes	 |
|HJV|	hemojuvelin BMP co-receptor	|	1q21.1|	Hemochromatosis	|	Bone morphogenic protein cofactor	|
|CDKN2A|cyclin dependent kinase inhibitor 2A	|	9p21.3	|		negative regulator of the proliferation of normal cells|	melanomic pancreatic cancer syndrome	|
|KRAS|KRAS proto-oncogene, GTPase|12p12.1|Plays an important role in the regulation of cell proliferation|	Noonan syndrome	|
|TP53|tumor protein p53|	17p13.1	|		Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type.|Lifraumeni syndrome		|
|FMR1|	FMRP translational regulator 1	|		Xq27.3|		Multifunctional polyribosome-associated RNA-binding protein that plays a central role in neuronal development and synaptic plasticity|Fragile X syndrome|
